KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Receivables (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Receivables for 13 consecutive years, with $6.7 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 42.14% to $6.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Dec 2025, up 42.14% year-over-year, with the annual reading at $6.7 million for FY2025, 42.14% up from the prior year.
  • Receivables hit $6.7 million in Q4 2025 for ClearPoint Neuro, up from $5.3 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $6.7 million in Q4 2025 to a low of $2.1 million in Q1 2021.
  • Historically, Receivables has averaged $3.5 million across 5 years, with a median of $3.1 million in 2023.
  • Biggest five-year swings in Receivables: skyrocketed 91.86% in 2021 and later decreased 16.4% in 2023.
  • Year by year, Receivables stood at $2.4 million in 2021, then increased by 22.77% to $3.0 million in 2022, then rose by 7.32% to $3.2 million in 2023, then surged by 46.78% to $4.7 million in 2024, then skyrocketed by 42.14% to $6.7 million in 2025.
  • Business Quant data shows Receivables for CLPT at $6.7 million in Q4 2025, $5.3 million in Q3 2025, and $4.8 million in Q2 2025.